Net income
1.31 million USD
2025-04-01 – 2026-03-31
Fundies. English
SL Science Holding Limited
EDGAR15 filing records in this dataset, filed from 2024-10-21 to 2026-05-20. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- Not available
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 2.18 million shares Source
Exact value
2180000 shares
Reported share-count change
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-972 thousand USD
2025-04-01 – 2026-03-31
Exact inputs and evidence
- Operating cash flow: -620690 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -281944 USD · 2025-01-01 – 2025-03-31 Source
- Operating cash flow: -880093 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -620690 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -1038803 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -880093 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -214981 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-05-20.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 2 of 11 periods available· newest 2025-12-31
- Operating cash flow: 2 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 2 of 11 periods available· newest 2025-12-31
- Total liabilities: 2 of 11 periods available· newest 2025-12-31
- Current assets: 2 of 11 periods available· newest 2025-12-31
- Current liabilities: 2 of 11 periods available· newest 2025-12-31
- cash and cash equivalents: No compatible figures in this window
- long term debt: No compatible figures in this window
- Shares outstanding: 2 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+1,166.1%Prior period
USD 142,877
–
Current period
USD 1.81 million
–
Exact inputs and evidence
1809006 − 142877 = 1666129 USD
142877 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1809006 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 928,338Prior period
−USD 110,465
–
Current period
−USD 1.04 million
–
Exact inputs and evidence
-1038803 − -110465 = -928338 USD
-110465 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-1038803 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2024 2024-01-01 – 2024-12-31 | USD 142,877 Exact valueExact value: 142877 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 110,465 Exact valueExact value: -110465 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 1.81 million Exact valueExact value: 1809006 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.04 million Exact valueExact value: -1038803 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
15 filings · 262 latest values · 262 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002032950, 2032950, edgar:2032950
Also known as HORIZON SPACE ACQUISITION II CORP., HORIZON SPACE ACQUISITION II CORP., Horizon Space Acquisition II Corp., SL Science Holding Limited